A. Craft

Articles in Scholarly Journals [Incomplete List]

  1. Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup
    JNCI Journal of the National Cancer Institute, vol. 99, no. 2, pp. 112–128, 2007
  2. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994
    British Journal of Cancer, vol. 94, no. 1, Article ID 6602885, 7 pages, 2006
  3. Relation between birth weight and soluble markers of endothelial function in middle aged subjects
    Heart, vol. 92, no. 5, pp. 679–680, 2006
  4. Modernizing medical careers: a response from the Academy of Medical Royal Colleges
    Journal of the Royal Society of Medicine, vol. 99, no. 4, pp. 165–167, 2006
  5. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial
    Pediatric Blood & Cancer, vol. 47, no. 1, pp. 22–29, 2006
  6. Cancer in adolescents and young adults aged 15-24 years: A report from the North of England young person's malignant disease registry, UK
    Pediatric Blood & Cancer, vol. 45, no. 5, pp. 687–693, 2005
  7. Second primary tumors in children and young adults in the North of England (1968-99)
    Pediatric Blood & Cancer, vol. 45, no. 2, pp. 155–161, 2005
  8. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study
    European Journal of Cancer, vol. 41, no. 2, pp. 225–230, 2005
  9. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance
    Journal of Immunological Methods, vol. 297, no. 1-2, pp. 143–152, 2005
  10. The National Service Framework for Children
    Archives of Disease in Childhood, vol. 90, no. 7, pp. 665–666, 2005
  11. Children with complex health care needs - supporting the child and family in the community
    Child: Care, Health and Development, vol. 30, no. 3, pp. 193–194, 2004
  12. Paediatrics in primary care
    Archives of Disease in Childhood, vol. 89, no. 2, pp. 112–112, 2004
  13. Munchausen syndrome by proxy and sudden infant death
    BMJ, vol. 328, no. 7451, pp. 1309–1312, 2004
  14. Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers
    Journal of Clinical Virology, vol. 30, no. 1, pp. 73–80, 2004
  15. Osteosarcoma: Is big always worse?
    Pediatric Blood & Cancer, vol. 43, no. 7, pp. 713–714, 2004
  16. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma
    Cancer, vol. 100, no. 10, pp. 2222–2232, 2004
  17. Detection of human respiratory syncytial virus genotype specific antibody responses in infants
    Journal of Medical Virology, vol. 74, no. 3, pp. 492–498, 2004
  18. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma
    Medical and Pediatric Oncology, vol. 40, no. 3, pp. 141–147, 2003
  19. Stature of young people with malignant bone tumors
    Pediatric Blood & Cancer, vol. 42, no. 1, pp. 59–63, 2003
  20. Postscript
    European Journal of Cancer, vol. 39, no. 18, pp. 2694–2695, 2003
  21. Changes in the human mitochondrial genome after treatment of malignant disease
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 525, no. 1-2, pp. 19–27, 2003
  22. The national service framework for children
    BMJ, vol. 326, no. 7395, pp. 891–892, 2003
  23. Melanoma Research, vol. 13, no. 4, pp. 421–426, 2003
  24. A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years
    Diabetic Medicine, vol. 20, no. 5, pp. 406–415, 2003
  25. Community paediatrics in the future: a personal view
    Current Paediatrics, vol. 12, no. 3, pp. 244–250, 2002
  26. Nephrotoxicity in survivors of Wilms' tumours in the North of England
    British Journal of Cancer, vol. 87, no. 10, Article ID 6600608, 6 pages, 2002
  27. Survival of children with bone sarcoma in Europe since 1978 results from the EUROCARE study
    European Journal of Cancer, vol. 37, no. 6, pp. 760–766, 2001
  28. Implications of childhood obesity for adult health: findings from thousand families cohort study
    BMJ, vol. 323, no. 7324, pp. 1280–1284, 2001
  29. Neuroblastoma: Changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry
    Medical and Pediatric Oncology, vol. 36, no. 1, pp. 231–234, 2001
  30. Letter to the editor: Ominous trend in childhood cancer mortality?
    Medical and Pediatric Oncology, vol. 36, no. 2, pp. 335–335, 2001
  31. Auditory function is unaffected by treatment with ifosfamide in children and adolescents
    Medical and Pediatric Oncology, vol. 35, no. 2, pp. 156–156, 2000
  32. Stillbirths among offspring of male radiation workers
    The Lancet, vol. 355, no. 9202, pp. 492–492, 2000
  33. Parent initiated and conventional preschool health surveillance
    Archives of Disease in Childhood, vol. 82, no. 4, pp. 336–336, 2000
  34. Risk of cardiovascular disease measured by carotid intima-media thickness at age 49-51: lifecourse study
    BMJ, vol. 320, no. 7230, pp. 273–278, 2000
  35. Childhood cancer - mainly curable so where next?
    Acta Paediatrica, vol. 89, no. 4, pp. 386–392, 2000
  36. Incidence and survival for cancer in children and young adults in the North of England, 1968–1995: a report from the Northern Region Young Persons’ Malignant Disease Registry
    British Journal of Cancer, vol. 83, no. 3, pp. 397–403, 2000
  37. Journal of Radiological Protection, vol. 17, no. 2, pp. 63–71, 1999
  38. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma
    European Journal of Cancer, vol. 35, no. 12, pp. 1698–1704, 1999
  39. Dose-related nephrotoxicity of carboplatin in children
    British Journal of Cancer, vol. 81, no. 2, pp. 336–341, 1999
  40. Growth rate of Wilms' tumour
    The Lancet, vol. 354, no. 9184, pp. 1127–1127, 1999
  41. Mothering skills and health in infancy: the Thousand Families study revisited
    The Lancet, vol. 353, no. 9159, pp. 1151–1152, 1999
  42. Stillbirths among offspring of male radiation workers at Sellafield nuclear reprocessing plant
    The Lancet, vol. 354, no. 9188, pp. 1407–1414, 1999
  43. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: The CESS 86 experience
    Medical and Pediatric Oncology, vol. 32, no. 3, pp. 186–195, 1999
  44. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy
    Medical and Pediatric Oncology, vol. 32, no. 3, pp. 196–200, 1999
  45. European experience with screening for neuroblastoma before the age of 12 months
    Medical and Pediatric Oncology, vol. 31, no. 5, pp. 442–449, 1998
  46. Annals of Oncology, vol. 9, no. 3, pp. 275–281, 1998
  47. Outcome and toxicity of an ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy
    Sarcoma, vol. 2, no. 3-4, pp. 171–177, 1998
  48. A randomized comparison of two short intensive chemotherapy regimens in children and young adults with osteosarcoma: results in patients with metastases: a study of the European Osteosarcoma Intergroup
    Sarcoma, vol. 1, no. 3-4, pp. 155–160, 1997
  49. Long-term results from the first UKCCSG Ewing's tumour study (ET-1)
    European Journal of Cancer, vol. 33, no. 7, pp. 1061–1069, 1997
  50. Challenges in the Management of Bone Tumors?1996
    Annals of the New York Academy of Sciences, vol. 824, no. 1 Challenges an, pp. 167–179, 1997
  51. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child
    Medical and Pediatric Oncology, vol. 28, no. 1, pp. 62–64, 1997
  52. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
    The Lancet, vol. 350, no. 9082, pp. 911–917, 1997
  53. Risk factors for ifosfamide nephrotoxicity in children
    The Lancet, vol. 348, no. 9027, pp. 578–580, 1996
  54. Radon and childhood cancers
    European Journal of Cancer, vol. 32, no. 2, pp. 201–204, 1996
  55. A phase II study of dacarbazine, cisplatin, interferon-a and high-dose interleukin-2 in 'poor-risk' metastatic melanoma
    European Journal of Cancer, vol. 32, no. 9, pp. 1530–1533, 1996
  56. Screening for neuroblastoma: 20 years and still no answer
    European Journal of Cancer, vol. 32, no. 9, pp. 1540–1543, 1996
  57. Osteogenic sarcoma in the Rothmund-Thomson syndrome
    Medical and Pediatric Oncology, vol. 26, no. 4, pp. 249–253, 1996
  58. Screening for wilms' tumour in patients with aniridia, Beckwith syndrome, or hemihypertrophy
    Medical and Pediatric Oncology, vol. 24, no. 4, pp. 231–234, 1995
  59. Granisetron as antiemetic therapy in children with cancer
    Medical and Pediatric Oncology, vol. 25, no. 1, pp. 28–32, 1995
  60. Osteogenic sarcoma of the neural arch
    Pediatric Radiology, vol. 25, no. 1, pp. 62–63, 1995
  61. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults
    Clinica Chimica Acta, vol. 236, no. 1, pp. 19–32, 1995
  62. Letter to the editor: Ifosfamide nephrotoxicity in children
    Medical and Pediatric Oncology, vol. 22, no. 2, pp. 153–154, 1994
  63. False positive results in a neuroblastoma screening programme
    Medical and Pediatric Oncology, vol. 22, no. 3, pp. 181–186, 1994
  64. Cytogenetic abnormalities of small round cell tumours
    Medical and Pediatric Oncology, vol. 23, no. 2, pp. 124–129, 1994
  65. Ifosfamide-induced hyperpigmentation
    Cancer, vol. 73, no. 1, pp. 240–241, 1994
  66. Chemotherapy in the management of infantile fibrosarcoma
    Medical and Pediatric Oncology, vol. 21, no. 7, pp. 488–493, 1993
  67. Low dose continuous infusion doxorubicin in children and young adults
    Medical and Pediatric Oncology, vol. 21, no. 7, pp. 494–498, 1993
  68. Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin
    Cancer Chemotherapy and Pharmacology, vol. 31, no. 5, pp. 415–418, 1993
  69. Myxoid liposarcoma of the porta hepatis in childhood
    Pediatric Radiology, vol. 23, no. 8, pp. 620–621, 1993
  70. Treatment of advanced neuroblastoma
    European Journal of Cancer, vol. 29, no. 2, pp. 292–293, 1993
  71. Adenoma of bronchiolar rest?a new entity
    Histopathology, vol. 23, no. 6, pp. 572–575, 1993
  72. p53 expression in three separate tumours from a patient with Li-Fraumeni's syndrome.
    Journal of Clinical Pathology, vol. 46, no. 7, pp. 676–677, 1993
  73. Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens.
    Journal of Clinical Pathology, vol. 45, no. 9, pp. 759–762, 1992
  74. Enterococcal superinfection in paediatric oncology patients treated with imipenem
    The Lancet, vol. 339, no. 8807, pp. 1487–1488, 1992
  75. High-dose rapid schedule chemotherapy for disseminated neuroblastoma
    European Journal of Cancer, vol. 28, no. 10, pp. 1654–1659, 1992
  76. Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma
    European Journal of Cancer, vol. 28, no. 8-9, pp. 1319–1323, 1992
  77. Comparison of saphenous versus jugular veins for central venous access in children with malignancy
    Journal of Pediatric Surgery, vol. 27, no. 5, pp. 609–611, 1992
  78. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening
    The Lancet, vol. 337, no. 8737, pp. 344–346, 1991
  79. Assessment of chemotherapy-associated nephrotoxicity in children with cancer
    Cancer Chemotherapy and Pharmacology, vol. 28, no. 2, pp. 81–92, 1991
  80. Cytogenetic analysis of a congenital fibrosarcoma
    Cancer Genetics and Cytogenetics, vol. 52, no. 1, pp. 37–41, 1991
  81. Neuroblastoma screening: More questions than answers?
    European Journal of Cancer and Clinical Oncology, vol. 27, no. 6, pp. 682–683, 1991
  82. Demonstration of Epstein-Barr viral DNA in formalin-fixed, paraffin-embedded samples of Hodgkin's disease
    The Journal of Pathology, vol. 161, no. 3, pp. 255–260, 1990
  83. Gonadal function after 12-Gy testicular irradiation in childhood acute lymphoblastic leukaemia
    Medical and Pediatric Oncology, vol. 18, no. 3, pp. 185–189, 1990
  84. Lack of response of bone marrow, in vitro, to growth factors in congenital neutropenia
    American Journal of Hematology, vol. 35, no. 2, pp. 125–126, 1990
  85. Local antibody production and respiratory syncytial virus infection in children with leukaemia
    Journal of Medical Virology, vol. 30, no. 4, pp. 277–281, 1990
  86. Virus infections in bone marrow transplant recipients: a three year prospective study.
    Journal of Clinical Pathology, vol. 43, no. 8, pp. 633–637, 1990
  87. Chromosome 22 abnormalities in Ewing's sarcoma.
    Journal of Clinical Pathology, vol. 42, no. 8, pp. 797–799, 1989
  88. NEPHROTOXICITY OF IFOSFAMIDE IN CHILDREN
    The Lancet, vol. 334, no. 8655, p. 159, 1989
  89. INVESTIGATION OF LEUKAEMIA CLUSTERS BY USE OF A GEOGRAPHICAL ANALYSIS MACHINE
    The Lancet, vol. 331, no. 8580, pp. 272–273, 1988
  90. TREATMENT OF OSTEOSARCOMA
    The Lancet, vol. 331, no. 8591, pp. 931–932, 1988
  91. Intestinal permeability during chemotherapy for childhood tumours
    European Journal of Pediatrics, vol. 147, no. 2, pp. 123–127, 1988
  92. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening
    Journal of Chromatography B: Biomedical Sciences and Applications, vol. 432, no. 1, pp. 273–277, 1988
  93. Radiological features of the long-term effects from treatment of malignant disease in childhood
    British Dental Journal, vol. 162, no. 3, Article ID 4806041, 3 pages, 1987
  94. Cytogenic investigations in the assessment of response to treatment in neuroblastoma.
    Journal of Clinical Pathology, vol. 40, no. 11, pp. 1334–1336, 1987
  95. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia
    Cancer Chemotherapy and Pharmacology, vol. 20, no. 3, pp. 243–247, 1987
  96. The long-term effects of treatment on the dental condition of children surviving malignant disease
    Cancer, vol. 60, no. 10, pp. 2570–2575, 1987
  97. SCREENING FOR NEUROBLASTOMA
    The Lancet, vol. 330, no. 8567, p. 1082, 1987
  98. CHILDHOOD CANCER IN WEST CUMBRIA
    The Lancet, vol. 325, no. 8425, pp. 403–404, 1985
  99. APPARENT CLUSTERS OF CHILDHOOD LYMPHOID MALIGNANCY IN NORTHERN ENGLAND
    The Lancet, vol. 324, no. 8394, pp. 96–97, 1984
  100. CHILDHOOD CANCER IN CUMBRIA
    The Lancet, vol. 322, no. 8362, p. 1299, 1983
  101. Four primary tumors in one child
    Cancer, vol. 52, no. 12, pp. 2363–2368, 1983
  102. Immunoglobulin concentrations in children receiving treatment for acute lymphoblastic leukaemia.
    Journal of Clinical Pathology, vol. 34, no. 5, pp. 479–482, 1981
  103. Fatal dissemination of cytomegalovirus after bone marrow transplantation
    Journal of Clinical Pathology, vol. 34, no. 9, pp. 1047–1051, 1981
  104. Complement fixing antibody responses to virus infection in children with acute lymphoblastic leukaemia.
    Journal of Clinical Pathology, vol. 33, no. 8, pp. 735–737, 1980
  105. CHILD-RESISTANT CONTAINERS
    The Lancet, vol. 315, no. 8159, pp. 97–98, 1980
  106. CHILD-RESISTANT CONTAINERS REALLY ARE EFFECTIVE
    The Lancet, vol. 314, no. 8141, p. 522, 1979
  107. Multiple virus isolations in children with acute lymphoblastic leukaemia
    Journal of Infection, vol. 1, no. 3, pp. 243–248, 1979
  108. BICYCLE SADDLES AND TORSION OF THE TESTIS
    The Lancet, vol. 311, no. 8071, pp. 983–984, 1978
  109. CHILD-RESISTANT PACKAGING AND ACCIDENTAL CHILD POISONING
    The Lancet, vol. 310, no. 8032, pp. 289–290, 1977
  110. POOR PROGNOSIS OF T-CELL LEUKqMIA IN CHILDREN
    The Lancet, vol. 310, no. 8047, pp. 1074–1075, 1977
  111. K CELLS IN LEUKqMIA
    The Lancet, vol. 308, no. 7985, p. 572, 1976